BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9914946)

  • 1. Subversion of cytokine networks by viruses.
    Wall EM; Cao JX; Upton C
    Int Rev Immunol; 1998; 17(1-4):121-55. PubMed ID: 9914946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines and viral anti-immune genes.
    Evans CH
    Stem Cells; 1996 Mar; 14(2):177-84. PubMed ID: 8991537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subversion and piracy: DNA viruses and immune evasion.
    Haig DM
    Res Vet Sci; 2001 Jun; 70(3):205-19. PubMed ID: 11676616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poxviral modifiers of cytokine responses to infection.
    Pickup DJ
    Infect Agents Dis; 1994; 3(2-3):116-27. PubMed ID: 7812650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral immune evasion: a masterpiece of evolution.
    Vossen MT; Westerhout EM; Söderberg-Nauclér C; Wiertz EJ
    Immunogenetics; 2002 Nov; 54(8):527-42. PubMed ID: 12439615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 'supervirus'? Lessons from IL-4-expressing poxviruses.
    Stanford MM; McFadden G
    Trends Immunol; 2005 Jun; 26(6):339-45. PubMed ID: 15922951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viruses know it all: new insights into IFN networks.
    Hengel H; Koszinowski UH; Conzelmann KK
    Trends Immunol; 2005 Jul; 26(7):396-401. PubMed ID: 15922665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Virokines and viroceptors--viral immunomodulators with clinical and therapeutic implications].
    Kontsek P; Kontsekova E
    Bratisl Lek Listy; 2000; 101(7):371-82. PubMed ID: 11059106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Was exposure to directly antiviral cytokines during primary infection an important selective pressure in the evolution of unique immune evasion strategies by viruses?
    Lidbury BA
    Immunol Cell Biol; 1994 Aug; 72(4):347-50. PubMed ID: 7528723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poxviruses and immune evasion.
    Seet BT; Johnston JB; Brunetti CR; Barrett JW; Everett H; Cameron C; Sypula J; Nazarian SH; Lucas A; McFadden G
    Annu Rev Immunol; 2003; 21():377-423. PubMed ID: 12543935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral exploitation and subversion of the immune system through chemokine mimicry.
    Murphy PM
    Nat Immunol; 2001 Feb; 2(2):116-22. PubMed ID: 11175803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-encoded chemokine receptors--putative novel antiviral drug targets.
    Rosenkilde MM
    Neuropharmacology; 2005 Jan; 48(1):1-13. PubMed ID: 15617722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral appropriation of apoptotic and NF-kappaB signaling pathways.
    Bowie AG; Zhan J; Marshall WL
    J Cell Biochem; 2004 Apr; 91(6):1099-108. PubMed ID: 15048867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology 101 at poxvirus U: immune evasion genes.
    Moss B; Shisler JL
    Semin Immunol; 2001 Feb; 13(1):59-66. PubMed ID: 11289800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy with poxvirus vectors.
    Moroziewicz D; Kaufman HL
    Curr Opin Mol Ther; 2005 Aug; 7(4):317-25. PubMed ID: 16121697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection control for gene therapy: a busy physician's primer.
    Evans ME; Lesnaw JA
    Clin Infect Dis; 2002 Sep; 35(5):597-605. PubMed ID: 12173136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral strategies for evading antiviral cellular immune responses of the host.
    Iannello A; Debbeche O; Martin E; Attalah LH; Samarani S; Ahmad A
    J Leukoc Biol; 2006 Jan; 79(1):16-35. PubMed ID: 16204622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The viral manipulation of the host cellular and immune environments to enhance propagation and survival: a focus on RNA viruses.
    Mahalingam S; Meanger J; Foster PS; Lidbury BA
    J Leukoc Biol; 2002 Sep; 72(3):429-39. PubMed ID: 12223509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral strategies in modulation of NF-kappaB activity.
    Lisowska K; Witkowski JM
    Arch Immunol Ther Exp (Warsz); 2003; 51(6):367-75. PubMed ID: 14692658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical knockout: understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genes.
    Johnston JB; McFadden G
    Cell Microbiol; 2004 Aug; 6(8):695-705. PubMed ID: 15236637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.